# OnCo record progressive-disease (term). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/terms/progressive-disease/>
  a schema:DefinedTerm ;
  onco:kind "term" ;
  schema:identifier "progressive-disease" ;
  schema:name "Progressive disease and radiographic progression"@en ;
  schema:alternateName "progressive disease"@en, "progression"@en, "disease progression"@en, "radiographic progression"@en, "radiological progression"@en, "clinical progression"@en, "progressed"@en, "progressing"@en, "on progression"@en, "at progression"@en, "after progression"@en, "post-progression"@en, "upon progression"@en, "time of progression"@en, "pseudoprogression"@en, "pseudo-progression"@en, "hyperprogression"@en, "iRECIST"@en, "iUPD"@en, "iCPD"@en, "PSA progression"@en, "biochemical progression"@en, "molecular progression"@en, "ctDNA progression"@en, "oligoprogressive"@en ;
  schema:description "The point at which a cancer is judged to be growing again despite treatment, usually a 20% increase on scans or a new lesion (RECIST). It ends progression-free survival, usually triggers a change of treatment, and defines 'lines' of therapy."@en ;
  schema:url <https://onco.cc/terms/progressive-disease/> ;
  schema:dateModified "2026-09-09"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Response_Evaluation_Criteria_in_Solid_Tumors> ;
  schema:citation <https://en.wikipedia.org/wiki/Response_Evaluation_Criteria_in_Solid_Tumors> ;
  onco:related <https://onco.cc/terms/pfs/>, <https://onco.cc/terms/recist/>, <https://onco.cc/terms/complete-response-term/>, <https://onco.cc/terms/first-line/>, <https://onco.cc/terms/oligometastatic/>, <https://onco.cc/terms/ctdna/> ;
  onco:sections <https://onco.cc/fronts/drug-discovery/> ;
  onco:trials <https://onco.cc/trials/serena-6/> .